Key result
Genetic and biochemical analysis of four patients with severe hypertriglyceridemia identified a novel disease-causing nonsense mutation in LMF1 (rs199953320) and overlapping multiple gene mutations, alongside elevated levels of specific phospholipids.
Why the study?
Severe hypertriglyceridemia is caused by genetic and environmental factors and can lead to acute pancreatitis, prompting exome sequencing and biochemical analysis in affected patients.
Observational (n=4)
No
The study identifies a novel LMF1 nonsense mutation and highlights the role of overlapping genetic mutations and specific phospholipids in the pathogenesis of severe hypertriglyceridemia and acute pancreatitis.
Does not support changes to clinical practice; hypothesis-generating for LMF1 variants in severe hypertriglyceridemia and requires validation.
Severe hypertriglyceridemia is a pathological condition caused by genetic factors alone or in combination with environmental factors, sometimes leading to acute pancreatitis (AP). In this study, exome sequencing and biochemical analyses were performed in 4 patients with hypertriglyceridemia complicated by obesity or diabetes with a history of AP or decreased post-heparin LPL mass. In a patient with a history of AP, SNP rs199953320 resulting in LMF1 nonsense mutation and APOE rs7412 causing apolipoprotein E2 were both found in heterozygous form. Three patients were homozygous for APOA5 rs2075291, and one was heterozygous. ELISA and Western blot analysis of the serum revealed the existence of apolipoprotein A-V in the lipoprotein-free fraction regardless of the presence or absence of rs2075291; furthermore, the molecular weight of apolipoprotein A-V was different depending on the class of lipoprotein or lipoprotein-free fraction. Lipidomics analysis showed increased serum levels of sphingomyelin and many classes of glycerophospholipid; however, when individual patients were compared, the degree of increase in each class of phospholipid among cases did not coincide with the increases seen in total cholesterol and triglycerides. Moreover, phosphatidylcholine, lysophosphatidylinositol, and sphingomyelin levels tended to be higher in patients who experienced AP than those who did not, suggesting that these phospholipids may contribute to the onset of AP. In summary, this study revealed a new disease-causing gene mutation in LMF1, confirmed an association between overlapping of multiple gene mutations and severe hypertriglyceridemia, and suggested that some classes of phospholipid may be involved in the pathogenesis of AP.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2024) conducted an observational in Severe hypertriglyceridemia (n=4). Genetic mutations and phospholipid alterations vs. Normal controls was evaluated on Identification of genetic mutations and phospholipid profiles. Genetic and biochemical analysis of four patients with severe hypertriglyceridemia identified a novel disease-causing nonsense mutation in LMF1 (rs199953320) and overlapping multiple gene mutations, alongside elevated levels of specific phospholipids.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: